72.11.Z - Research and experimental development on biotechnology
63.99.Z - Other information service activities not elsewhere classified
66.19.Z - Other activities auxiliary to financial services, except insurance and pension funding
70.22.Z - Business and other management consultancy activities
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
82.30.Z - Organisation of conventions and trade shows
82.99.Z - Other business support service activities not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | -0,2 | -0,2 | 21,6 |
EBITDA | -0 | -0,2 | -0,2 | -2,5 |
Short time liabilities | 0,6 | 0,2 | 0,7 | 315,8 |
Equity capital | 2,6 | 2,4 | 2,2 | -8,1 |
Operating profit (EBIT) | -0,1 | -0,2 | -0,2 | 8,2 |
Assets | 3,2 | 2,5 | 2,9 | 13,8 |
Net profit (loss) | -0,1 | -0,2 | -0,2 | 21,6 |
Cash | 0 | 0 | 0,4 | 14 538,3 |
Net income from sale | 0,1 | 0 | 0 | -70,8 |
Liabilities and provisions for liabilities | 0,6 | 0,2 | 0,7 | 315,8 |
Working assets | 0,9 | 1,1 | 1,5 | 35,4 |
Depreciation | 0,1 | 0,1 | 0 | -38,6 |
% | % | % | p.p. | |
Profitability of capital | -4 | -10,3 | -8,8 | 1,5 |
Equity capital to total assets | 81,4 | 93,2 | 75,3 | -17,9 |
Gross profit margin | -94,2 | -689,6 | -1848,7 | -1159,1 |
EBITDA Margin | -22,6 | -434,9 | -1524,5 | -1089,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 1833 | 1769 | 25 156 | 23 387 |
Current financial liquidity indicator | 1.6566778421401978 | 6.322708606719971 | 2.058837890625 | -4,2 |
Net dept to EBITDA | -12.66588306427002 | -0.3001560866832733 | -1.1149945259094238 | -0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane